Valvulopathy is among the most frequent cardiac pathologies in our environment and represents a major health problem due to the high annual morbidity and mortality rate involved, as well as the high economic cost of its treatment. The evolution in recent years in the knowledge of its pathophysiology, as well as its diagnosis and treatment has been exponential, to the point that the creation of specialised Valvulopathy Units in referral centers is currently recommended. Pathophysiologically, the concept of this disease and its study has evolved, and the latest clinical practice guidelines highlight the fact that haemodynamic alteration and the association with other cardiovascular and multi-valve diseases play a determining role in its assessment and in the decision-making on the treatment of choice. The techniques for valvular assessment and their treatment have multiplied, especially due to the development of new surgical and percutaneous treatments. Furthermore, the emergence of new cardiovascular drugs has opened up new treatment pathways for these diseases.
This Special Issue is a collection of review articles, original articles and meta-analyses aimed to address different current issues and future visions on the pathophysiology, diagnosis and treatment of valvular heart disease.
Prof. Sergio Moral and Prof. Arturo Evangelista
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.
Valvulopathy and Genetics: Where are We?
Dr. Ramon Brugada, et al.
Cardiac Imaging in Percutaneous Tricuspid Procedures
Dr. Francisco Calvo, et al.